Radiation necrosis of the brain in melanoma patients successfully treated with ipilimumab, three case studies
Authors:
- Stephanie Du FourSFStephanie Du Four
- Sofie WilgenhofSWSofie Wilgenhof
- Johnny DuerinckJDJohnny Duerinck
- Alex MichotteAMAlex Michotte
- Anne Van BinstABAnne Van Binst
- Mark De RidderMark De Ridder
- Bart NeynsBNBart Neyns
- 1 November 2012
- journal article
- case report
- Published by Elsevier in European Journal of Cancer
- Vol. 48 (16) , 3045-3051
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosisRadiation Oncology, 2011
- Anti-CTLA-4 antibody-induced Guillain–Barré syndrome in a melanoma patientAnnals of Oncology, 2011
- Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 StudyJournal of Clinical Oncology, 2011
- Brain Metastasis in Melanoma: Clinical Activity of CTLA-4 Antibody TherapySeminars in Oncology, 2010
- Successful Treatment of Melanoma Brain Metastases with Adoptive Cell TherapyClinical Cancer Research, 2010
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- Complete regression of a previously untreated melanoma brain metastasis with ipilimumabMelanoma Research, 2010
- Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trialThe Lancet Oncology, 2009
- CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNSNature Clinical Practice Oncology, 2008
- Temozolomide in advanced malignant melanoma with small brain metastasesCancer, 2007